Development and maintenance of FDA-argos 2 universal closed systems for pathogen reduction in donated
Ended Definitive Contract Awarded Last action
- Contract number
- 75F40121C00194
- Awardee
-
Zata Pharmaceuticals, Inc. UEI LM1CSJF7LLS6
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $6,692,768
Award facts
- Opportunity
-
- FY21 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science Solicitation · FDABAA2100123 · Posted Nov 20, 2020
- Contract value 100% obligated
- $6,692,767.70 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 10 offers Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Silver Spring, MD 20993, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$5,863,963 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $5,476,220 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $4,785,967 | |
| Other Administrative Action | $0 | |
| Original award | $2,294,544 |
About this award
The Food and Drug Administration awarded a $6.69 million definitive contract to Zata Pharmaceuticals, Inc. for development and maintenance of FDA-ARGOS 2 universal closed systems for pathogen reduction in donated whole blood units on September 27, 2021. The contract carries cost-no-fee pricing and a ceiling value of $6,692,767.70.
Place of performance is Silver Spring, MD. The originating Broad Agency Announcement solicited research and development proposals across eight areas of regulatory science, including manufacturing modernization and evaluation of emerging technologies, under PSC code AJ11. The award reflects a September 2021 selection from a BAA posted November 20, 2020 with a January 28, 2021 submission deadline. A no-cost modification extended the ultimate completion date to March 26, 2025.
Quick answers
Who was awarded contract 75F40121C00194?
75F40121C00194 was awarded to Zata Pharmaceuticals, Inc. by Food and Drug Administration (Department of Health and Human Services) on September 27, 2021.
How much is contract 75F40121C00194 worth?
The government has obligated $6,692,768 on 75F40121C00194.
Was contract 75F40121C00194 competed?
The extent of competition for 75F40121C00194 was full and open competition. The government received 10 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award